| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein antigen binding | 3.98e-07 | 16 | 79 | 4 | GO:1990405 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.55e-05 | 2 | 79 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.55e-05 | 2 | 79 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.62e-05 | 15 | 79 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 4.62e-05 | 3 | 79 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | receptor ligand inhibitor activity | 9.23e-05 | 4 | 79 | 2 | GO:0141069 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 7.73e-04 | 104 | 79 | 4 | GO:0016407 | |
| GeneOntologyCellularComponent | septin complex | 1.84e-05 | 14 | 79 | 3 | GO:0031105 | |
| GeneOntologyCellularComponent | septin ring | 1.84e-05 | 14 | 79 | 3 | GO:0005940 | |
| GeneOntologyCellularComponent | septin cytoskeleton | 2.81e-05 | 16 | 79 | 3 | GO:0032156 | |
| GeneOntologyCellularComponent | extracellular matrix | 8.12e-04 | 656 | 79 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 8.30e-04 | 658 | 79 | 9 | GO:0030312 | |
| HumanPheno | Plantar crease between first and second toes | 3.35e-05 | 2 | 30 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 3.35e-05 | 2 | 30 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 3.35e-05 | 2 | 30 | 2 | HP:0001042 | |
| HumanPheno | Hydrocele testis | 5.05e-05 | 36 | 30 | 4 | HP:0000034 | |
| HumanPheno | Hypoplastic aortic arch | 6.42e-05 | 14 | 30 | 3 | HP:0012304 | |
| HumanPheno | Clinodactyly of the 5th finger | 8.68e-05 | 420 | 30 | 10 | HP:0004209 | |
| HumanPheno | Clinodactyly of hands | 8.86e-05 | 421 | 30 | 10 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 8.86e-05 | 421 | 30 | 10 | HP:0009179 | |
| HumanPheno | Laryngeal cartilage malformation | 1.00e-04 | 3 | 30 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.00e-04 | 3 | 30 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.00e-04 | 3 | 30 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.00e-04 | 3 | 30 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.00e-04 | 3 | 30 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.00e-04 | 3 | 30 | 2 | HP:0005895 | |
| HumanPheno | Supernumerary tooth | 1.18e-04 | 85 | 30 | 5 | HP:0011069 | |
| HumanPheno | Radial deviation of finger | 1.50e-04 | 448 | 30 | 10 | HP:0009466 | |
| HumanPheno | Finger clinodactyly | 1.61e-04 | 452 | 30 | 10 | HP:0040019 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | 1.74e-04 | 456 | 30 | 10 | HP:0009485 | |
| HumanPheno | Trichiasis | 2.00e-04 | 4 | 30 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 2.00e-04 | 4 | 30 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 2.00e-04 | 4 | 30 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 2.00e-04 | 4 | 30 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 2.00e-04 | 4 | 30 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 2.00e-04 | 4 | 30 | 2 | HP:0031207 | |
| HumanPheno | Self-mutilation | 2.02e-04 | 51 | 30 | 4 | HP:0000742 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 3.32e-04 | 5 | 30 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 3.32e-04 | 5 | 30 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 3.32e-04 | 5 | 30 | 2 | HP:0030421 | |
| HumanPheno | Abnormal 5th finger morphology | 4.30e-04 | 509 | 30 | 10 | HP:0004207 | |
| HumanPheno | Aortic valve stenosis | 4.50e-04 | 113 | 30 | 5 | HP:0001650 | |
| HumanPheno | Abnormal number of teeth | 4.90e-04 | 421 | 30 | 9 | HP:0006483 | |
| HumanPheno | Large foramen magnum | 4.96e-04 | 6 | 30 | 2 | HP:0002700 | |
| HumanPheno | Deviation of finger | 6.62e-04 | 537 | 30 | 10 | HP:0004097 | |
| HumanPheno | Deviated nasal septum | 6.91e-04 | 7 | 30 | 2 | HP:0004411 | |
| HumanPheno | Functional abnormality of male internal genitalia | CFAP47 NDNF ADAMTS3 FEZF1 P3H1 DNAH17 EHMT1 ZMYM2 CRPPA PLAG1 LTBP1 BCOR CREBBP EP300 CASZ1 DNAH11 | 7.57e-04 | 1269 | 30 | 16 | HP:0000025 |
| HumanPheno | Unsteady gait | 8.01e-04 | 357 | 30 | 8 | HP:0002317 | |
| MousePheno | abnormal mammary gland connective tissue morphology | 1.63e-05 | 2 | 57 | 2 | MP:0009507 | |
| MousePheno | ectropion | 1.63e-05 | 2 | 57 | 2 | MP:0006164 | |
| MousePheno | esophageal ulcer | 1.63e-05 | 2 | 57 | 2 | MP:0004547 | |
| MousePheno | duodenal ulcer | 1.63e-05 | 2 | 57 | 2 | MP:0003273 | |
| MousePheno | perianal ulcer | 1.63e-05 | 2 | 57 | 2 | MP:0005035 | |
| MousePheno | incomplete somite formation | 2.99e-05 | 44 | 57 | 4 | MP:0001689 | |
| MousePheno | perimembraneous ventricular septal defect | 3.54e-05 | 92 | 57 | 5 | MP:0010418 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 3.73e-05 | 93 | 57 | 5 | MP:0008823 | |
| MousePheno | absent cornea epithelium | 4.89e-05 | 3 | 57 | 2 | MP:0020856 | |
| MousePheno | ventricular septal defect | 8.70e-05 | 261 | 57 | 7 | MP:0010402 | |
| MousePheno | increased circulating fibrinogen level | 9.75e-05 | 4 | 57 | 2 | MP:0012331 | |
| MousePheno | abnormal epicardium development | 9.75e-05 | 4 | 57 | 2 | MP:0031590 | |
| MousePheno | proctitis | 9.75e-05 | 4 | 57 | 2 | MP:0003305 | |
| MousePheno | persistent dorsal ophthalmic artery | 1.62e-04 | 5 | 57 | 2 | MP:0013992 | |
| MousePheno | abnormal ophthalmic artery morphology | 2.42e-04 | 6 | 57 | 2 | MP:0020489 | |
| MousePheno | gastric ulcer | 2.42e-04 | 6 | 57 | 2 | MP:0003282 | |
| MousePheno | increased acute phase protein level | 3.39e-04 | 7 | 57 | 2 | MP:0014499 | |
| MousePheno | abnormal pericardium development | 3.39e-04 | 7 | 57 | 2 | MP:0031587 | |
| MousePheno | venoocclusion | 3.39e-04 | 7 | 57 | 2 | MP:0006137 | |
| MousePheno | abnormal conjunctival epithelium morphology | 3.39e-04 | 7 | 57 | 2 | MP:0004481 | |
| MousePheno | peptic ulcer | 3.39e-04 | 7 | 57 | 2 | MP:0003301 | |
| MousePheno | atrial septal defect | 4.49e-04 | 88 | 57 | 4 | MP:0010403 | |
| MousePheno | abnormal circulating fibrinogen level | 4.50e-04 | 8 | 57 | 2 | MP:0010213 | |
| MousePheno | decreased keratinocyte migration | 4.50e-04 | 8 | 57 | 2 | MP:0012194 | |
| MousePheno | abnormal interventricular septum morphology | 4.56e-04 | 342 | 57 | 7 | MP:0000281 | |
| MousePheno | decreased susceptibility to induced choroidal neovascularization | 7.20e-04 | 10 | 57 | 2 | MP:0003434 | |
| MousePheno | abnormal kidney thrombosis | 7.20e-04 | 10 | 57 | 2 | MP:0011507 | |
| MousePheno | abnormal vein morphology | 7.37e-04 | 176 | 57 | 5 | MP:0002725 | |
| MousePheno | abnormal neurocranium morphology | 7.66e-04 | 269 | 57 | 6 | MP:0000074 | |
| MousePheno | abnormal axon guidance | 8.08e-04 | 45 | 57 | 3 | MP:0002961 | |
| MousePheno | impaired somite development | 8.44e-04 | 104 | 57 | 4 | MP:0009768 | |
| MousePheno | subcutaneous edema | 8.62e-04 | 46 | 57 | 3 | MP:0013848 | |
| MousePheno | abnormal keratinocyte migration | 8.78e-04 | 11 | 57 | 2 | MP:0012192 | |
| MousePheno | abnormal interatrial septum morphology | 9.38e-04 | 107 | 57 | 4 | MP:0000282 | |
| MousePheno | internal hemorrhage | 9.47e-04 | 387 | 57 | 7 | MP:0001634 | |
| MousePheno | abnormal heart septum morphology | 9.61e-04 | 388 | 57 | 7 | MP:0006113 | |
| MousePheno | abnormal craniofacial morphology | ADAMTS3 FEZF2 FEZF1 LRRC32 EHMT1 PLAG1 ACTN4 LTBP1 SIK3 ITGA4 CREBBP EP300 TNFRSF11B DNAH11 | 9.72e-04 | 1372 | 57 | 14 | MP:0000428 |
| MousePheno | craniofacial phenotype | ADAMTS3 FEZF2 FEZF1 LRRC32 EHMT1 PLAG1 ACTN4 LTBP1 SIK3 ITGA4 CREBBP EP300 TNFRSF11B DNAH11 | 9.72e-04 | 1372 | 57 | 14 | MP:0005382 |
| Domain | Nuc_rcpt_coact_CREBbp | 1.59e-05 | 2 | 75 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.59e-05 | 2 | 75 | 2 | PF08214 | |
| Domain | KIX | 1.59e-05 | 2 | 75 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 1.59e-05 | 2 | 75 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.59e-05 | 2 | 75 | 2 | IPR031162 | |
| Domain | DUF902 | 1.59e-05 | 2 | 75 | 2 | PF06001 | |
| Domain | - | 1.59e-05 | 2 | 75 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.59e-05 | 2 | 75 | 2 | IPR010303 | |
| Domain | - | 1.59e-05 | 2 | 75 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.59e-05 | 2 | 75 | 2 | PF09030 | |
| Domain | - | 1.59e-05 | 2 | 75 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.59e-05 | 2 | 75 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.59e-05 | 2 | 75 | 2 | PS50134 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.59e-05 | 2 | 75 | 2 | IPR013178 | |
| Domain | KAT11 | 1.59e-05 | 2 | 75 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.59e-05 | 2 | 75 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.59e-05 | 2 | 75 | 2 | IPR003101 | |
| Domain | KIX | 1.59e-05 | 2 | 75 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.59e-05 | 2 | 75 | 2 | PS51727 | |
| Domain | Septin | 1.73e-05 | 13 | 75 | 3 | PF00735 | |
| Domain | G_SEPTIN_dom | 1.73e-05 | 13 | 75 | 3 | IPR030379 | |
| Domain | G_SEPTIN | 1.73e-05 | 13 | 75 | 3 | PS51719 | |
| Domain | Septin | 2.19e-05 | 14 | 75 | 3 | IPR016491 | |
| Domain | Znf_C2H2 | GTF2H2 ZNF473 ZNF544 FEZF2 FEZF1 ZNF592 ZNF549 PLAG1 ZNF322 ZNF770 CASZ1 ZNF681 | 8.12e-05 | 805 | 75 | 12 | IPR007087 |
| Domain | Bromodomain_CS | 1.51e-04 | 26 | 75 | 3 | IPR018359 | |
| Domain | Nuc_rcpt_coact | 2.36e-04 | 6 | 75 | 2 | IPR009110 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF473 ZNF544 FEZF2 FEZF1 ZNF592 ZNF549 PLAG1 ZNF322 ZNF770 CASZ1 ZNF681 | 2.54e-04 | 775 | 75 | 11 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF473 ZNF544 FEZF2 FEZF1 ZNF592 ZNF549 PLAG1 ZNF322 ZNF770 CASZ1 ZNF681 | 2.59e-04 | 777 | 75 | 11 | PS00028 |
| Domain | Kringle-like | 2.84e-04 | 32 | 75 | 3 | IPR013806 | |
| Domain | Znf_C2H2-like | ZNF473 ZNF544 FEZF2 FEZF1 ZNF592 ZNF549 PLAG1 ZNF322 ZNF770 CASZ1 ZNF681 | 3.19e-04 | 796 | 75 | 11 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF473 ZNF544 FEZF2 FEZF1 ZNF592 ZNF549 PLAG1 ZNF322 ZNF770 CASZ1 ZNF681 | 3.62e-04 | 808 | 75 | 11 | SM00355 |
| Domain | zf-C2H2 | ZNF473 ZNF544 FEZF2 FEZF1 ZNF592 ZNF549 ZNF322 ZNF770 CASZ1 ZNF681 | 4.35e-04 | 693 | 75 | 10 | PF00096 |
| Domain | BROMODOMAIN_1 | 4.38e-04 | 37 | 75 | 3 | PS00633 | |
| Domain | Bromodomain | 4.74e-04 | 38 | 75 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 5.94e-04 | 41 | 75 | 3 | PS50014 | |
| Domain | BROMO | 6.38e-04 | 42 | 75 | 3 | SM00297 | |
| Domain | Bromodomain | 6.38e-04 | 42 | 75 | 3 | IPR001487 | |
| Domain | - | 6.38e-04 | 42 | 75 | 3 | 1.20.920.10 | |
| Domain | - | 1.55e-03 | 679 | 75 | 9 | 3.30.160.60 | |
| Domain | zf-C2H2_6 | 1.64e-03 | 314 | 75 | 6 | PF13912 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 1.80e-03 | 694 | 75 | 9 | IPR013087 | |
| Domain | Kringle | 2.08e-03 | 17 | 75 | 2 | IPR000001 | |
| Domain | Kringle_CS | 2.08e-03 | 17 | 75 | 2 | IPR018056 | |
| Domain | KRINGLE_2 | 2.08e-03 | 17 | 75 | 2 | PS50070 | |
| Domain | Kringle | 2.08e-03 | 17 | 75 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 2.08e-03 | 17 | 75 | 2 | PS00021 | |
| Domain | KR | 2.08e-03 | 17 | 75 | 2 | SM00130 | |
| Domain | ZZ | 2.34e-03 | 18 | 75 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 2.34e-03 | 18 | 75 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.34e-03 | 18 | 75 | 2 | PS01357 | |
| Domain | Znf_ZZ | 2.60e-03 | 19 | 75 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 2.60e-03 | 19 | 75 | 2 | SM00291 | |
| Domain | C2H2_Znf_fam | 4.15e-03 | 24 | 75 | 2 | IPR027775 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 1.43e-04 | 129 | 55 | 5 | M39693 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.48e-04 | 5 | 55 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.48e-04 | 5 | 55 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.48e-04 | 5 | 55 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.48e-04 | 5 | 55 | 2 | M27228 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.22e-04 | 6 | 55 | 2 | M22062 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.10e-04 | 7 | 55 | 2 | MM1573 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 4.12e-04 | 8 | 55 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 4.12e-04 | 8 | 55 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 4.12e-04 | 8 | 55 | 2 | M48024 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 4.12e-04 | 8 | 55 | 2 | M47850 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 4.12e-04 | 8 | 55 | 2 | M46443 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 5.29e-04 | 9 | 55 | 2 | M47451 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 6.59e-04 | 10 | 55 | 2 | M27945 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 6.65e-04 | 44 | 55 | 3 | M27295 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 8.04e-04 | 11 | 55 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 8.04e-04 | 11 | 55 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 8.04e-04 | 11 | 55 | 2 | M26924 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 9.62e-04 | 12 | 55 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 9.62e-04 | 12 | 55 | 2 | M27765 | |
| Pathway | BIOCARTA_FIBRINOLYSIS_PATHWAY | 9.62e-04 | 12 | 55 | 2 | MM1398 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 1.15e-03 | 53 | 55 | 3 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 1.28e-03 | 55 | 55 | 3 | M39351 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.32e-03 | 14 | 55 | 2 | M27808 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.32e-03 | 14 | 55 | 2 | MM1458 | |
| Pathway | BIOCARTA_SET_PATHWAY | 1.32e-03 | 14 | 55 | 2 | MM1403 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.52e-03 | 15 | 55 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.52e-03 | 15 | 55 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.52e-03 | 15 | 55 | 2 | MM1439 | |
| Pathway | REACTOME_DISSOLUTION_OF_FIBRIN_CLOT | 1.52e-03 | 15 | 55 | 2 | MM15450 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.52e-03 | 15 | 55 | 2 | M953 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 1.57e-03 | 59 | 55 | 3 | M39886 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 1.64e-03 | 130 | 55 | 4 | MM15455 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.73e-03 | 16 | 55 | 2 | M27121 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.73e-03 | 16 | 55 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.73e-03 | 16 | 55 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.73e-03 | 16 | 55 | 2 | M8516 | |
| Pathway | WP_BDNF_PATHWAY | 1.73e-03 | 16 | 55 | 2 | MM15816 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.73e-03 | 16 | 55 | 2 | M27940 | |
| Pathway | REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS | 1.96e-03 | 17 | 55 | 2 | M27104 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.96e-03 | 17 | 55 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 1.96e-03 | 17 | 55 | 2 | M48025 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 2.07e-03 | 65 | 55 | 3 | M39682 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | BRPF3 GTF2H2 ZNF473 ZNF544 SCMH1 ZNF549 RAD1 EHMT1 ZNF770 ITGA4 CREBBP EP300 ZNF681 | 2.17e-03 | 1387 | 55 | 13 | M734 |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION | 2.20e-03 | 18 | 55 | 2 | MM15342 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.20e-03 | 18 | 55 | 2 | M26942 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.45e-03 | 19 | 55 | 2 | M18933 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION | 2.45e-03 | 19 | 55 | 2 | M27639 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 2.45e-03 | 19 | 55 | 2 | M46442 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 2.69e-03 | 768 | 55 | 9 | MM14851 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 2.69e-03 | 360 | 55 | 6 | M27267 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.71e-03 | 20 | 55 | 2 | M27881 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 2.88e-03 | 73 | 55 | 3 | M638 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 2.99e-03 | 21 | 55 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 2.99e-03 | 21 | 55 | 2 | M27485 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 3.25e-03 | 157 | 55 | 4 | MM15226 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.26e-03 | 258 | 55 | 5 | MM14572 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.28e-03 | 22 | 55 | 2 | MM1370 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.28e-03 | 22 | 55 | 2 | MM1443 | |
| Pathway | WP_ESTROGEN_SIGNALING | 3.35e-03 | 77 | 55 | 3 | MM15934 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 3.48e-03 | 160 | 55 | 4 | M27498 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.59e-03 | 23 | 55 | 2 | M2821 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 3.59e-03 | 23 | 55 | 2 | MM15936 | |
| Pubmed | Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis. | 5.04e-08 | 4 | 82 | 3 | 1986355 | |
| Pubmed | 2.63e-06 | 638 | 82 | 10 | 31182584 | ||
| Pubmed | 4.46e-06 | 529 | 82 | 9 | 14621295 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 27881875 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 31690812 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 30254165 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 5.49e-06 | 2 | 82 | 2 | 34845315 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24913420 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 38328826 | ||
| Pubmed | Reduced transplant arteriosclerosis in plasminogen-deficient mice. | 5.49e-06 | 2 | 82 | 2 | 9819364 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 19729597 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 15860545 | ||
| Pubmed | Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice. | 5.49e-06 | 2 | 82 | 2 | 10634603 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 29460469 | ||
| Pubmed | Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis. | 5.49e-06 | 2 | 82 | 2 | 23943648 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 12083480 | ||
| Pubmed | Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice. | 5.49e-06 | 2 | 82 | 2 | 18420257 | |
| Pubmed | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | 5.49e-06 | 2 | 82 | 2 | 7705657 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 23041318 | ||
| Pubmed | Plasminogen alleles influence susceptibility to invasive aspergillosis. | 5.49e-06 | 2 | 82 | 2 | 18566672 | |
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 5.49e-06 | 2 | 82 | 2 | 24551300 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 20152183 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 19752236 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 6216475 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 33911074 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 9018065 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24648406 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 30135524 | ||
| Pubmed | The generation and characterization of mice expressing a plasmin-inactivating active site mutation. | 5.49e-06 | 2 | 82 | 2 | 20653841 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 12428098 | ||
| Pubmed | Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. | 5.49e-06 | 2 | 82 | 2 | 20440070 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 5.49e-06 | 2 | 82 | 2 | 16596650 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24732409 | ||
| Pubmed | A central role for plasminogen in the inflammatory response to biomaterials. | 5.49e-06 | 2 | 82 | 2 | 15456492 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24876560 | ||
| Pubmed | Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice. | 5.49e-06 | 2 | 82 | 2 | 24574269 | |
| Pubmed | Spontaneous development of otitis media in plasminogen-deficient mice. | 5.49e-06 | 2 | 82 | 2 | 16956791 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 25409527 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 1543918 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 8704243 | ||
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 5.49e-06 | 2 | 82 | 2 | 29217654 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 38637838 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 17267741 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 20717166 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 10049825 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 23702659 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 29990619 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 5.49e-06 | 2 | 82 | 2 | 27380996 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 17293777 | ||
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 5.49e-06 | 2 | 82 | 2 | 29170789 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 25893291 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 11559821 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 5.49e-06 | 2 | 82 | 2 | 12646247 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 28245922 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 23456978 | ||
| Pubmed | Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. | 5.49e-06 | 2 | 82 | 2 | 10854210 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 32576962 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 19822209 | ||
| Pubmed | Gender affects skin wound healing in plasminogen deficient mice. | 5.49e-06 | 2 | 82 | 2 | 23527289 | |
| Pubmed | Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. | 5.49e-06 | 2 | 82 | 2 | 22079981 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24522976 | ||
| Pubmed | Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. | 5.49e-06 | 2 | 82 | 2 | 9490683 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 5.49e-06 | 2 | 82 | 2 | 21847097 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 16481742 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 18983515 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 34378815 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 11848464 | ||
| Pubmed | Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. | 5.49e-06 | 2 | 82 | 2 | 7586361 | |
| Pubmed | Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function. | 5.49e-06 | 2 | 82 | 2 | 21239499 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 10642175 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 12225871 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 9770530 | ||
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 5.49e-06 | 2 | 82 | 2 | 11963968 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 5.49e-06 | 2 | 82 | 2 | 34813504 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 16314561 | ||
| Pubmed | Plasminogen activation is required for the development of radiation-induced dermatitis. | 5.49e-06 | 2 | 82 | 2 | 30323258 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 5.49e-06 | 2 | 82 | 2 | 12696060 | |
| Pubmed | Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. | 5.49e-06 | 2 | 82 | 2 | 37971174 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 9884337 | ||
| Pubmed | Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice. | 5.49e-06 | 2 | 82 | 2 | 26473342 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 10816371 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 20301699 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 5.49e-06 | 2 | 82 | 2 | 36109165 | |
| Pubmed | Plasminogen is a critical regulator of cutaneous wound healing. | 5.49e-06 | 2 | 82 | 2 | 26791370 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24639469 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 37816914 | ||
| Pubmed | Selection of mutant µplasmin for amyloid-β cleavage in vivo. | 5.49e-06 | 2 | 82 | 2 | 32694536 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 7525077 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 12242694 | ||
| Pubmed | Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. | 5.49e-06 | 2 | 82 | 2 | 16052596 | |
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 5.49e-06 | 2 | 82 | 2 | 11438528 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 17122079 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 10918613 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 31182547 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 16103174 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 35502657 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q26 | 3.72e-04 | 16 | 82 | 2 | chr6q26 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q24 | 4.50e-04 | 355 | 82 | 5 | chr8q24 | |
| Cytoband | 6q26 | 4.73e-04 | 18 | 82 | 2 | 6q26 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF473 ZNF544 FEZF2 FEZF1 ZNF592 ZNF549 PLAG1 ZNF322 ZNF770 CASZ1 ZNF681 | 4.90e-06 | 718 | 52 | 11 | 28 |
| GeneFamily | Septins | 6.29e-06 | 13 | 52 | 3 | 732 | |
| GeneFamily | Dyneins, axonemal | 1.07e-03 | 17 | 52 | 2 | 536 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.07e-03 | 17 | 52 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.21e-03 | 18 | 52 | 2 | 91 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 9.45e-03 | 51 | 52 | 2 | 870 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-06 | 182 | 82 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 184 | 82 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 185 | 82 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.24e-06 | 186 | 82 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-05 | 156 | 82 | 5 | abea3c183d32062b009a79a2bdf861021989c7ef | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 162 | 82 | 5 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 1.75e-05 | 174 | 82 | 5 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.80e-05 | 175 | 82 | 5 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.80e-05 | 175 | 82 | 5 | bee8f31f036dfcf9fc6ed29156554771a9ee3c60 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 182 | 82 | 5 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-maDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.23e-05 | 183 | 82 | 5 | e01dacb08a9c36cf09c0b6764ce032a7232d4cdc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 186 | 82 | 5 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-05 | 186 | 82 | 5 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.48e-05 | 187 | 82 | 5 | 406ff9327d3109fe1e251629c4c617b00a573dc2 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.88e-05 | 193 | 82 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.25e-05 | 198 | 82 | 5 | 72aad5b2dcd8b0bde58828fa4f8129fe6cb6a21d | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-05 | 199 | 82 | 5 | f4ab29f99ce45a3044d2e9f356dc24d3c5e7121f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.41e-05 | 200 | 82 | 5 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 3.41e-05 | 200 | 82 | 5 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-04 | 141 | 82 | 4 | dcc56aef1b31bfe0de84cb0b5c77d242681cf19c | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 1.34e-04 | 141 | 82 | 4 | 7671d300b1722711fd2d8034b96a3aa7e3ccb560 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.53e-04 | 146 | 82 | 4 | 447c05414eda71681a0c07baba900f88ed6165ed | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-04 | 148 | 82 | 4 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-04 | 149 | 82 | 4 | cc6224c6b79f43b97adc1ce48ca4906bff2ad318 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-04 | 149 | 82 | 4 | 24a7538b54b2a5291503c7493fefed4e45e8d710 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.78e-04 | 152 | 82 | 4 | 0fda8980b10ce16179dea92301db74d728f41794 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.78e-04 | 152 | 82 | 4 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 156 | 82 | 4 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 156 | 82 | 4 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 158 | 82 | 4 | 90ca742739a208d457db087655ba3d1c18a9da57 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 160 | 82 | 4 | 8dae9b0cf90a09acb196223f45a14680102630b2 | |
| ToppCell | cellseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-ILC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.28e-04 | 162 | 82 | 4 | 553f91eaba72bcffb733ede45418bbee39c653ab | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.33e-04 | 163 | 82 | 4 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.39e-04 | 164 | 82 | 4 | e24b06a14565f7798ac50c2fe3f34d4547b9000e | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 165 | 82 | 4 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | COVID-19_Mild-PLT_0|COVID-19_Mild / Disease Group and Platelet Clusters | 2.44e-04 | 165 | 82 | 4 | 083a14d3b0162cee4e79f7398b8fb739582b39ff | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.50e-04 | 166 | 82 | 4 | c8fd241088de27c6e741a5dfee3cd770183b6bcb | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-04 | 167 | 82 | 4 | eed22d1a17aab84dacb1a488528bae9389644cb9 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-04 | 170 | 82 | 4 | d9ed257d0938442d0bb280e4c4b0c9b657511b46 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 170 | 82 | 4 | 3ad9f950b87ee98f025ab9b4a8ed551e6a9b4764 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.80e-04 | 171 | 82 | 4 | f1fdc0ec3399ed6955976d02be7e5fc329a64276 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 2.86e-04 | 172 | 82 | 4 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.92e-04 | 173 | 82 | 4 | 51328a60ffaf34fa0f7df6084d348b5efc9917f5 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.92e-04 | 173 | 82 | 4 | b77cd5dbda3a206922f20224f4e10a3bf712f7db | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.99e-04 | 174 | 82 | 4 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-04 | 175 | 82 | 4 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | metastatic_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.12e-04 | 176 | 82 | 4 | 9c1f255de3082b3da4bef2a9bdff710cfd48261f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-04 | 177 | 82 | 4 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-04 | 177 | 82 | 4 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 178 | 82 | 4 | d9eba884e18a0c89bdc70c194bfe4d62cca164fa | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 178 | 82 | 4 | b03aa1de9d20895ebad55f6fcd6fe7a49335db5a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.26e-04 | 178 | 82 | 4 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 178 | 82 | 4 | 0f5cf34609df791c8baebfdc6590f6eb4dbe0509 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.33e-04 | 179 | 82 | 4 | af03705a783e77f75c44fdfa793cfdccbf9dd91c | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.33e-04 | 179 | 82 | 4 | 0e22e840f43ca81a7543dcf33ec17a741cdf7f37 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.33e-04 | 179 | 82 | 4 | 17ba1eedb6ebf039d3b11d099351d0ac6363c8d1 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.33e-04 | 179 | 82 | 4 | 7046f0a426e45fe1b41a25721ee1e33f6fc7f9e3 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue-2|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.33e-04 | 179 | 82 | 4 | a20bb3ace5be10c5aef330e9268c0ba55f8fee23 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-04 | 180 | 82 | 4 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-04 | 180 | 82 | 4 | 392bc71a69653ba12de31bed4e9357f181094641 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.47e-04 | 181 | 82 | 4 | 8fd64404e57c22c204d835fc5626f73554257b19 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-04 | 181 | 82 | 4 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-04 | 181 | 82 | 4 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.47e-04 | 181 | 82 | 4 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-04 | 182 | 82 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | remission-Platelet|remission / disease stage, cell group and cell class | 3.54e-04 | 182 | 82 | 4 | 65e2798aacd670cbc3a8c8e9d1a2f7768513bb70 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-04 | 182 | 82 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.54e-04 | 182 | 82 | 4 | da61e7cb2537c567968d8bd8baf537ecdff0ab18 | |
| ToppCell | Cerebellum-Endothelial-MURAL|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.54e-04 | 182 | 82 | 4 | b2f03f61aebb5920595fed8b9d6799a09353419b | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-04 | 183 | 82 | 4 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-04 | 184 | 82 | 4 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega-Megakaryocyte_early|lymph-node_spleen / Manually curated celltypes from each tissue | 3.69e-04 | 184 | 82 | 4 | 10607d7d92edcbb92d992900086b90b307421cc3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.77e-04 | 185 | 82 | 4 | c985a4b184d382a79aaff07f81c0efede2c2d493 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.77e-04 | 185 | 82 | 4 | d0d0e000ebe1fc35a987930ceaf7e3369e0c694c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.77e-04 | 185 | 82 | 4 | 0ca99fcbd30c454bcdc2aa5265a0e4dba25666ea | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-04 | 185 | 82 | 4 | a3b937163346d729115e6335336e33d3e71fccb0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.77e-04 | 185 | 82 | 4 | 0f722ffcc3e78d5c6b1b79d31d00929801a993f1 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.85e-04 | 186 | 82 | 4 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Platelet|World / Lineage, cell class and subclass | 3.85e-04 | 186 | 82 | 4 | 27807334e7241c8a9aeaf6403f0fd0b001fbc0d1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-04 | 186 | 82 | 4 | 6568358812f0ca4e0161a1a1b29682fbced35c79 | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.85e-04 | 186 | 82 | 4 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | (2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(2)_5-FU / Stress and Cell class | 3.92e-04 | 187 | 82 | 4 | 6bbf0f7fe203274dae8d582652f35cd3187c0065 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-04 | 187 | 82 | 4 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.92e-04 | 187 | 82 | 4 | d17352f769c3c66601b65d060626eecff41b0482 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-04 | 187 | 82 | 4 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.92e-04 | 187 | 82 | 4 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.00e-04 | 188 | 82 | 4 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.00e-04 | 188 | 82 | 4 | 5eb107122064f0a99dfd445cc87d3766f7257216 | |
| ToppCell | 11.5-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 4.00e-04 | 188 | 82 | 4 | 916971d8660fd20f616346953874e89d2cd13e88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-04 | 188 | 82 | 4 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | 15-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 4.00e-04 | 188 | 82 | 4 | 4963382e54aac06bf5047c7d725393db70667ee7 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17|Lung / Manually curated celltypes from each tissue | 4.09e-04 | 189 | 82 | 4 | f43960506ed3e699e910ec7711c1113e2e9b80d1 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 4.09e-04 | 189 | 82 | 4 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.17e-04 | 190 | 82 | 4 | 2ff4b50b864a35f22c558d7d585cd2b54612b50c | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.17e-04 | 190 | 82 | 4 | 55df73c8b696967a925b1772631f6900eff0fa30 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.17e-04 | 190 | 82 | 4 | e1b721bb74561fe51c53328a0394c9954e489049 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.17e-04 | 190 | 82 | 4 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-04 | 190 | 82 | 4 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells|World / Lineage, cell class and subclass | 4.17e-04 | 190 | 82 | 4 | 72b61a12ccea506272ce9cef9051aa2612e6ce57 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.17e-04 | 190 | 82 | 4 | 494fbab37305a7f92cddec75b291d42282555f5f | |
| Drug | Fibrin | 3.72e-06 | 9 | 82 | 3 | CID000439199 | |
| Drug | aminopropylsilane | 9.68e-06 | 12 | 82 | 3 | CID006337902 | |
| Disease | Menke-Hennekam syndrome | 6.37e-06 | 2 | 75 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 6.37e-06 | 2 | 75 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 6.37e-06 | 2 | 75 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 6.37e-06 | 2 | 75 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 6.37e-06 | 2 | 75 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 6.37e-06 | 2 | 75 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 6.37e-06 | 2 | 75 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 6.37e-06 | 2 | 75 | 2 | C0035934 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 6.34e-05 | 5 | 75 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | plasma plasminogen measurement | 6.34e-05 | 5 | 75 | 2 | EFO_0006309 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 8.92e-05 | 34 | 75 | 3 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | retinitis pigmentosa | 9.50e-05 | 6 | 75 | 2 | MONDO_0019200 | |
| Disease | angiostatin measurement | 9.50e-05 | 6 | 75 | 2 | EFO_0008024 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.15e-04 | 37 | 75 | 3 | EFO_0022252 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 1.33e-04 | 7 | 75 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | platelet measurement | 1.53e-04 | 315 | 75 | 6 | EFO_0005036 | |
| Disease | Carcinoma, Transitional Cell | 1.57e-04 | 41 | 75 | 3 | C0007138 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 1.69e-04 | 42 | 75 | 3 | EFO_0022255 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.81e-04 | 43 | 75 | 3 | EFO_0022290 | |
| Disease | mean platelet volume | 2.52e-04 | 1020 | 75 | 10 | EFO_0004584 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 2.84e-04 | 50 | 75 | 3 | EFO_0022303 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 3.01e-04 | 51 | 75 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 3.01e-04 | 51 | 75 | 3 | EFO_0022240 | |
| Disease | triglycerides in HDL measurement | 3.37e-04 | 53 | 75 | 3 | EFO_0022317 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 3.37e-04 | 53 | 75 | 3 | EFO_0022286 | |
| Disease | polyunsaturated fatty acid measurement | 3.53e-04 | 131 | 75 | 4 | EFO_0010733 | |
| Disease | triglycerides in medium HDL measurement | 3.56e-04 | 54 | 75 | 3 | EFO_0022321 | |
| Disease | triglycerides in LDL measurement | 3.97e-04 | 56 | 75 | 3 | EFO_0022320 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 3.97e-04 | 56 | 75 | 3 | EFO_0022333 | |
| Disease | cholesterol to total lipids in large LDL percentage | 3.97e-04 | 56 | 75 | 3 | EFO_0022235 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 3.97e-04 | 56 | 75 | 3 | EFO_0022251 | |
| Disease | triglycerides to total lipids in small LDL percentage | 4.63e-04 | 59 | 75 | 3 | EFO_0022337 | |
| Disease | sexual dimorphism measurement | BRPF3 TRANK1 ADAMTS3 ZNF592 SCMH1 LPA PLAG1 ZNF322 LTBP1 SIK3 | 4.78e-04 | 1106 | 75 | 10 | EFO_0021796 |
| Disease | triglycerides to total lipids in large HDL percentage | 4.86e-04 | 60 | 75 | 3 | EFO_0022330 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 4.86e-04 | 60 | 75 | 3 | EFO_0022237 | |
| Disease | Hypercalcemia | 4.88e-04 | 13 | 75 | 2 | C0020437 | |
| Disease | Milk-Alkali Syndrome | 4.88e-04 | 13 | 75 | 2 | C0026141 | |
| Disease | triglycerides in small VLDL measurement | 5.11e-04 | 61 | 75 | 3 | EFO_0022145 | |
| Disease | free cholesterol in HDL measurement | 5.11e-04 | 61 | 75 | 3 | EFO_0022264 | |
| Disease | triglycerides in medium LDL measurement | 5.36e-04 | 62 | 75 | 3 | EFO_0022322 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 5.36e-04 | 62 | 75 | 3 | EFO_0022339 | |
| Disease | triglycerides in small HDL measurement | 5.36e-04 | 62 | 75 | 3 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 5.36e-04 | 62 | 75 | 3 | EFO_0022169 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 5.61e-04 | 63 | 75 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 5.61e-04 | 63 | 75 | 3 | EFO_0022239 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 5.61e-04 | 63 | 75 | 3 | EFO_0022283 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 5.88e-04 | 64 | 75 | 3 | EFO_0022253 | |
| Disease | triglycerides in small LDL measurement | 6.15e-04 | 65 | 75 | 3 | EFO_0022323 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 6.72e-04 | 67 | 75 | 3 | EFO_0022245 | |
| Disease | triglycerides to phosphoglycerides ratio | 7.02e-04 | 68 | 75 | 3 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 7.02e-04 | 68 | 75 | 3 | EFO_0022265 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 7.33e-04 | 69 | 75 | 3 | EFO_0022341 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 7.48e-04 | 16 | 75 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in small HDL percentage | 8.29e-04 | 72 | 75 | 3 | EFO_0022336 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 8.98e-04 | 74 | 75 | 3 | EFO_0022280 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 9.34e-04 | 75 | 75 | 3 | EFO_0022287 | |
| Disease | Leukemia, Myelocytic, Acute | 1.00e-03 | 173 | 75 | 4 | C0023467 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 1.05e-03 | 78 | 75 | 3 | EFO_0022187 | |
| Disease | cerebral infarction (is_marker_for) | 1.06e-03 | 19 | 75 | 2 | DOID:3526 (is_marker_for) | |
| Disease | cholesterol in large HDL measurement | 1.13e-03 | 80 | 75 | 3 | EFO_0021900 | |
| Disease | Deep Vein Thrombosis | 1.30e-03 | 21 | 75 | 2 | C0149871 | |
| Disease | Venous Thrombosis | 1.30e-03 | 21 | 75 | 2 | C0042487 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 1.62e-03 | 197 | 75 | 4 | EFO_0005680 | |
| Disease | Coronary heart disease | 1.70e-03 | 24 | 75 | 2 | C0010068 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 1.85e-03 | 95 | 75 | 3 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.90e-03 | 96 | 75 | 3 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 2.08e-03 | 99 | 75 | 3 | EFO_0004611, EFO_0007878 | |
| Disease | Adenoid Cystic Carcinoma | 2.14e-03 | 100 | 75 | 3 | C0010606 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.22e-03 | 215 | 75 | 4 | EFO_0008317, EFO_0008591 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 2.26e-03 | 102 | 75 | 3 | EFO_0004329, EFO_0004611 | |
| Disease | antipsychotic drug use measurement | 2.48e-03 | 29 | 75 | 2 | EFO_0007792 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.52e-03 | 106 | 75 | 3 | EFO_0008317, EFO_0008596 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CRAFQYHSKEQQCVI | 61 | Q02325 | |
| NRYHFCEKCFNEIQG | 1196 | Q09472 | |
| QSQDRFVYTCNECKH | 1661 | Q09472 | |
| GTCNEFKECHAIRNY | 171 | Q9UBR2 | |
| VKETNVNYTICQCDH | 2706 | Q8IZF6 | |
| FIDQFKALHQCNKYC | 2111 | Q86TB3 | |
| YCFCNNEVQTTVKRQ | 391 | P30988 | |
| CKYNQVNSHFHCIRE | 1291 | Q86V15 | |
| CSNHVYYAKRVLCSQ | 111 | Q8NEB7 | |
| VQKDCQCERLFHGNY | 166 | P20718 | |
| YDSHNVNTRCQKICD | 486 | O43707 | |
| QNRYHFCEKCFTEIQ | 1231 | Q92793 | |
| QKHCFVNICDAQFQY | 1841 | Q96DT5 | |
| KVNCYTAFHVTCAQR | 341 | Q9ULD4 | |
| QVCSTFTLCLHYRNQ | 131 | Q8TAP6 | |
| RRGFQVYKQVCASCH | 111 | P08574 | |
| YCLENKICDVNHRDN | 1481 | Q6W2J9 | |
| EQIYSCVYKCVCQQH | 161 | Q86Y37 | |
| EAFHCNQTQVNRYKI | 211 | O60671 | |
| HYIQVLNCKQNCVTE | 271 | Q32P28 | |
| HLQQIILDQCYNFVC | 326 | A4D126 | |
| KLICVRYFQTCGNVH | 16 | P11182 | |
| FTRDYCHNVLNCQVL | 826 | Q5H9U9 | |
| YKRVNNTFCQDINEC | 616 | Q14766 | |
| QVCEKRASQQFCYTN | 56 | O14524 | |
| FQNCCYNFIITKNRH | 1251 | O60449 | |
| YCVVINKEHNFKSLC | 211 | Q8TB73 | |
| CRAFQYHSKEQQCVI | 61 | Q15195 | |
| LCVARHKFYRLNQCN | 296 | Q16825 | |
| RLTFCNSNIIQHFYC | 181 | Q8NGV6 | |
| AACCCVRRQKFNQQY | 646 | Q14392 | |
| CYGKQRCKIIVNNHH | 226 | P58658 | |
| EYQLCNTEECQKHFE | 596 | O15072 | |
| EIYLESCCQARYHQK | 126 | Q14721 | |
| ATKYICQNFEAVCQT | 156 | Q9NXS3 | |
| QCKNQCHENEIRIAY | 41 | Q30KQ9 | |
| LCQYKFDFLQEVCQH | 1091 | Q96BY6 | |
| RHCFANICDAQIQYS | 1796 | Q9UFH2 | |
| ADDCLVQRVTQHKCY | 141 | Q9Y324 | |
| LNKQFCYTVEQHNRE | 411 | Q8IWJ2 | |
| LFHLYAACKSINQEC | 91 | A6NN92 | |
| LVIENEVCNHYKYIC | 1961 | P08519 | |
| AKFRQIVSAVQYCHQ | 161 | Q9P0L2 | |
| ECHFENYQRVCALEQ | 851 | P13612 | |
| CHVQCTNNTQLRVDY | 201 | Q17R55 | |
| CQQYHSFCAQENVQR | 616 | Q8IXB1 | |
| RADHQACINFYCTQF | 2716 | Q6ZTR5 | |
| NIDRNITHLQYCVCI | 1051 | Q9H9B1 | |
| YINEFSVRKCHTCQN | 501 | P02748 | |
| CTICNKAFHQVYNLT | 391 | Q8TBJ5 | |
| NHCEINCQKIAEYLS | 206 | Q96DY7 | |
| ELKDQHVYVCAVCQN | 351 | Q6P1K8 | |
| CTYKNQECRLTIHYE | 446 | Q13884 | |
| SFHNNVYRDSIIVCC | 311 | P30531 | |
| KNIQDNRVHCCLYFI | 246 | O43236 | |
| KNIQDNRVHCCLYFI | 146 | Q99719 | |
| INQLFRNEKHCRNCF | 871 | Q9NTG1 | |
| QFKCNICNKAFHQVY | 371 | A0PJY2 | |
| QIVTAVYFCHCRNIV | 171 | Q9Y2K2 | |
| SAFNIYCNVRHCVLE | 146 | O75592 | |
| QQCHKELQQAYCELS | 326 | A8MXQ7 | |
| CRAFQYHSKEQQCVI | 61 | P00747 | |
| QAVQACIDCAYHQKT | 396 | Q96GD3 | |
| VHTGRKDFLCQYCAQ | 206 | Q6DJT9 | |
| RKNIQDSRVHCCLYF | 131 | Q8WYJ6 | |
| YFSNQAVRACILCVH | 321 | Q14690 | |
| QYVKQECNRTHNRVC | 91 | O00300 | |
| QRTHNAEKPYVCNIC | 266 | Q6P9A3 | |
| CSIQHCLYQFTRNEK | 631 | Q9Y5T5 | |
| RVFCQICQHYLTNVN | 766 | Q8N3U4 | |
| ELKDQHVYVCAVCQN | 351 | Q13888 | |
| LCRSAYFQTHVKENC | 776 | Q92610 | |
| HIYQCLECKQNFCEN | 41 | Q6U7Q0 | |
| NNSKICTIECYVHNL | 191 | A6NIE6 | |
| HQEKNDVFLYRCSVC | 616 | Q6IQ21 | |
| CDQHCLLRFYCQQNE | 791 | Q9UBW7 | |
| HQCARAFCQSIYLSK | 216 | Q6NX49 | |
| TQHKIICTRVNFYKC | 186 | Q96N22 | |
| KCACQFQCHTNYIPV | 96 | Q8IYR6 | |
| SQCYKDAFRCFEQIQ | 1806 | O15050 | |
| RICHRELYSVKQQFC | 106 | Q96HE9 | |
| YRVEAIQCQTCSKSH | 266 | A6NP61 | |
| SRFHNCLIQLYCEKV | 616 | Q96JC1 | |
| HTQETLYQCQRCQKA | 836 | Q8WTR7 |